The "5th Annual Circulating Biomarkers and Extracellular Vesicles Europe 2023" conference has been added to ResearchAndMarkets.com's offering. The Circulating Biomarkers Extracellular Vesicles Europe
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
A key recommendation from Quebec coroner Géhane Kamel s recent scathing report on the deaths at the CHSLD Herron residence was that the government allow its public health director complete independence "without political constraints."
Roughly three million rapid COVID-19 tests are set to be distributed to Quebec Tuesday. At five tests per box, that means about 600,000 boxes will be available.